Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial-Reference-Cited by-同舟云学术

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial

Published:1999-01 Issue:9149 Volume:353 Page:259-266
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Smolen Josef S,Kalden Joachim R,Scott David L,Rozman Blaz,Kvien Tore K,Larsen Arvi,Loew-Friedrich Iris,Oed Christine,Rosenburg Ronald

Publisher

Elsevier BV

Subject

General Medicine

Reference43 articles.

1. What is the natural history of rheumatoid arthritis?;Pincus;Rheum Dis Clin North Am,1993

2. Prognostic factors, radiographic damage and physical disability in early rheumatoid arthritis: a prospective follow-up study of 147 patients;van der Heijde;Br J Rheumatol,1992

3. Early rheumatoid arthritis—onset, course, and outcome over 2 years;Eberhardt;Rheumatol Int,1990

4. Second-line drug therapy for rheumatoid arthritis;Cash;N Engl J Med,1994

5. Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981–1996;Ward;J Rheumatol,1998

Cited by 628 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Prospects in Rheumatoid Arthritis: Pathophysiology, Genetics, and Treatments;Recent Advances in Anti-Infective Drug Discovery;2024-04

2. Folate decorated chitosan-chondroitin sulfate nanoparticles loaded hydrogel for targeting macrophages against rheumatoid arthritis;Carbohydrate Polymers;2024-03

3. Advances in non-biological drugs for the treatment of rheumatoid arthritis;Expert Opinion on Pharmacotherapy;2023-12-22

4. Rheumatoid arthritis and cardiovascular comorbidities;Exploration of Musculoskeletal Diseases;2023-12-06

5. Elderly-Onset Rheumatoid Arthritis: Characteristics and Treatment Options;Medicina;2023-10-23